In recent days, Recursion Pharmaceuticals attracted heightened attention as traders responded to the stock’s very large short interest, alongside the announcement of a $12.5 million milestone payment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback